REGU-MATE SOLUTION 0.22% DIN 00641987
Health Canada record
| Active ingredient(s) | ALTRENOGEST 2.2 MG |
|---|---|
| Dosage form | Solution |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1986 |
| Current status date | 28-Apr-2006 |
| Source | Health Canada DPD |
Establishment licence of the holder
Intervet Canada Corp. — licence 100147, currently licensed, last inspection rating C (2023-07-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ALTRENOGEST
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02464047 | ALTERMATE | ARIVAC INC. | Solution | ALTRENOGEST 2.2 MG | Approved |
| 02519135 | ALTREN SOLUTION 0.22% | AURORA PHARMACEUTICAL, INC. | Solution | ALTRENOGEST 2.2 MG | Marketed |
| 02454882 | ALTRESYN | CEVA ANIMAL HEALTH INC | Solution | ALTRENOGEST 2.2 MG | Dormant |
| 00870919 | REGU-MATE GEL 2.15MG/G | INTERVET CANADA CORP | Gel | ALTRENOGEST 2.15 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 10131 | 2009-04-03 | Supplement to a New Drug Submission (SNDS) | Alternate manufacturing site |
| 7912 | 2006-04-27 | Supplement to a New Drug Submission (SNDS) | ALTERNATE SOURCE OF ACTIVE INGREDIENT |
| 6820 | 2005-05-20 | Supplement to a New Drug Submission (SNDS) | NEW SPECIES, NEW CLINICAL CLAIMS |
| 6201 | 2001-06-13 | New Drug Submission (NDS) |
International API supply for ALTRENOGEST
1 active FDA Drug Master Files.
Request a quote for REGU-MATE SOLUTION 0.22%